黑料网

E-ISSN: 2314-7326
P-ISSN: 2314-7334

Journal of Neuroinfectious Diseases
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Chickenpox: Understanding The Viral Infection, Symptoms and Management

Hongyi Lin*
Department of neuroscience, Columbia University, China
*Corresponding Author: Hongyi Lin, Department of neuroscience, Columbia University, China, Email: hongyil23@gmail.com

Received Date: Nov 01, 2024 / Published Date: Nov 29, 2024

Citation: Hongyi L (2024) Chickenpox: Understanding The Viral Infection, Symptoms and Management. J Neuroinfect Dis 15: 534.DOI: 10.4172/2314-7326.1000534

Copyright: © 2024 Hongyi L. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Chickenpox, or varicella, is a highly contagious viral infection caused by the varicella-zoster virus (VZV). Primarily affecting children, chickenpox manifests with a characteristic itchy rash, fever, and general malaise. The transmission occurs through respiratory droplets and direct contact with blister fluid, making it easily spreadable in communities with low vaccination rates. The disease typically presents with mild symptoms in children but can lead to serious complications in adults and immunocompromised individuals, including pneumonia, bacterial skin infections, and neurological issues.The introduction of the varicella vaccine has dramatically reduced the incidence of chickenpox and its complications. Vaccination is usually administered in two doses, with the first dose given at 12-15 months and a second at 4-6 years of age. This vaccine not only protects individuals but also contributes to herd immunity, significantly lowering the risk of outbreaks. Despite the vaccine’s success, challenges remain, particularly in areas with vaccine hesitancy, which can lead to increased cases.Management of chickenpox focuses on symptomatic relief, including the use of antihistamines for itching and acetaminophen for fever. Antiviral medications, such as acyclovir, may be prescribed for high-risk individuals to mitigate severe disease.

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top